Opinion: redefining the role of the physician in laboratory medicine in the context of emerging technologies, personalised medicine and patient autonomy (‘4P medicine’)
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The role of clinical pathologists or laboratory-based physicians is being challenged on several fronts—exponential advances in technology, increasing patient autonomy exercised in the right to directly request tests and the use of non-medical specialists as substitutes. In response, clinical pathologists have focused their energies on the pre-analytical and postanalytical phases of Laboratory Medicine thus emphasising their essential role in individualised medical interpretation of complex laboratory results. Across the European Union, the role of medical doctors is enshrined in the Medical Act. This paper highlights the relevance of this act to patient welfare and the need to strengthen training programmes to prevent an erosion in the quality of Laboratory Medicine provided to patients and their physicians.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hood, L., & Flores, M. (2012) · New Biotechnology · doi:10.1016/j.nbt.2012.03.004 · Cited by 648
From biomarkers to medical tests: the changing landscape of test evaluation
Horvath, A. R., Lord, S. J., StJohn, A., Sandberg, S., Cobbaert, C. M., Lorenz, S., Monaghan, P. J., Verhagen-Kamerbeek, W. D. J., Ebert, C., & Bossuyt, P. M. M. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.09.018 · Cited by 203
Research works printed but not linked: 35
- 10.1136/jclinpath-2012-201042 · DOI
- Price, 2016, Leveraging the real value of laboratory medicine with the value proposition, Clin Chim Acta, 462, 183, 10.1016/j.cca.2016.09.006 · DOI
- Wegscheider, 2015, Bundesgesundheitsblatt gesundheitsforschung gesundheitsschutz, 58, 298
- Hamilton W , Hajioff S , Graham J , et al . Suspected cancer (part 2—adults): reference tables from updated NICE guidance. BMJ: British Medical Journal 2015;350. · DOI
- Plebani, 2013, Harmonization in laboratory medicine: the complete picture, Clin Chem Lab Med, 51, 741, 10.1515/cclm-2013-0075 · DOI · Paper page
- Lippi, 2015, Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for clinical chemistry and laboratory medicine (EFLM) Working group for Preanalytical Phase (WG-PRE), Clin Chem Lab Med, 53, 357, 10.1515/cclm-2014-1051 · DOI · Paper page
- Oosterhuis, 2015, Laboratory medicine in the European Union, Clin Chem Lab Med, 53, 5, 10.1515/cclm-2014-0407 · DOI
- 10.1258/jmb.2012.012005 · doi:10.1258/jmb.2012.012005
- Ferraro, 2016, Laboratory medicine in the new healthcare environment, Clin Chem Lab Med, 54, 523, 10.1515/cclm-2015-0803 · DOI
- Aarsand, 2014, How to achieve harmonisation of laboratory testing -The complete picture, Clin Chim Acta, 432, 8, 10.1016/j.cca.2013.12.005 · DOI
- Orth, 2017, Direct-to-consumer testing: the business with lifestyle tests, Point of Care, 16, 124, 10.1097/POC.0000000000000144 · DOI
- Diamandis, 2015, Theranos phenomenon: promises and fallacies, Clin Chem Lab Med, 53, 989, 10.1515/cclm-2015-0356 · doi:10.1515/cclm-2015-0356
- Carreyrou J , Siconolfi M , Weaver C . Theranos dealt sharp blow as elizabeth holmes is banned from operating labs. Wall Street Journal 2016.
- Gabler E . Hidden errors - a watchdog report - common medical tests escape scrutiny but often fall short. Milwaukee Journal Sentinel http://archive.jsonline.com/watchdog/watchdogreports/common-medical-tests-escape-scrutiny-but-often-fall-short-1-b99570945z1-338990781.html/ (accessed 30 Sep 2017).
- 10.1515/cclm.2011.617 · DOI
- Orth, 2011, Practical implications of the german genetic diagnostics act (gendg) for laboratory medicine, the human genetics laboratory and for genetic counseling, LaboratoriumsMedizin, 35, 243, 10.1515/JLM.2011.045 · doi:10.1515/jlm.2011.045
- 10.1056/NEJM197507312930506 · DOI · Paper page
- 10.1309/AJCP4GS7KSBDBACF · DOI
- 10.1001/jama.2008.803 · DOI · Paper page
- 10.1186/gm514 · DOI · Paper page
- 10.1373/clinchem.2015.248112 · doi:10.1373/clinchem.2015.248112
- Bresó, 2015, Knowledge-based personal health system to empower outpatients of diabetes mellitus by means of p4 medicine, Methods Mol Biol, 1246, 237, 10.1007/978-1-4939-1985-7_15 · DOI
- Watson, 2015, European views on patients directly obtaining their laboratory test results, Clin Chem Lab Med, 53, 1961, 10.1515/cclm-2015-0056 · DOI
- Orth, 2015, Direct-To-Consumer-Testing: Fluch oder Segen für die Patienten?, Dtsch Arztebl International, 112, 174
- Armbruster, 2014, Clinical chemistry laboratory automation in the 21st century - amat victoria curam (Victory loves careful preparation), Clin Biochem Rev, 35, 143
- Badrick, 2017, External quality assessment beyond the analytical phase: an australian perspective, Biochem Med, 27, 73, 10.11613/BM.2017.009 · DOI
- 10.1111/j.1467-8519.2007.00550.x · DOI
- Dennick, 2015, Written emotional disclosure for adults with Type 2 diabetes: a primary care feasibility study, Prim Health Care Res Dev, 16, 179, 10.1017/S1463423614000188 · DOI
- 10.1373/clinchem.2015.248591 · doi:10.1373/clinchem.2015.248591
- Cornel, 2014, The challenge of implementing genetic tests with clinical utility while avoiding unsound applications, J Community Genet, 5, 7, 10.1007/s12687-012-0121-1 · DOI
- 10.1038/ejhg.2010.129 · DOI
- Maillet, 2011, Apprentissage tout au long de la vie pour les médecins spécialistes en Europe : formation médicale continue, développement professionnel continu et qualifications, Presse Med, 40, 357, 10.1016/j.lpm.2011.01.014 · doi:10.1016/j.lpm.2011.01.014
- 10.1093/ndt/gfr535 · DOI
- Australian commission on safety and quality in health care. Review of serious failures in reported test results for prostatespecific antigen (PSA) testing of patients by SA pathology.Secondary Review of serious failures in reported test results for prostatespecific antigen (PSA) testing of patients by sa pathology. 2016 https://www.hcasa.asn.au/documents/273-psa-review/file (accessed 30 Sep 2017).
- De Vooght, 2016, New mAb therapies in multiple myeloma: interference with blood transfusion compatibility testing, Curr Opin Hematol, 23, 557, 10.1097/MOH.0000000000000276 · DOI
Cited by
A Review of the Role of Artificial Intelligence in Healthcare
Al Kuwaiti, A., Nazer, K., Al-Reedy, A., Al-Shehri, S., Al-Muhanna, A., Subbarayalu, A. V., Al Muhanna, D., & Al-Muhanna, F. A. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13060951 · Cited by 915
Artificial Intelligence in Medicine: Today and Tomorrow
Briganti, G., & Le Moine, O. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00027 · Cited by 743
Vanstapel, F. J. L. A., Orth, M., Streichert, T., Capoluongo, E. D., Oosterhuis, W. P., Çubukçu, H. C., Bernabeu-Andreu, F. A., Thelen, M., Jacobs, L. H. J., Linko, S., et al. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0045 · Cited by 45
Self-citationArtificial Intelligence: Knowledge and Attitude Among Lebanese Medical Students
Daher, O. A., Dabbousi, A. A., Chamroukh, R., Saab, A. Y., Al Ayoubi, A. R., & Salameh, P. (2024) · Cureus · doi:10.7759/cureus.51466 · Cited by 16
“The general public has embraced AI because it enables a 4P model of medicine (predictive, preventive, personalized, and participatory) and, consequently, patient autonomy in previously impossible ways [7].”
Metadata
- Authors
- Orth, M., Averina, M., Chatzipanagiotou, S., Faure, G., Haushofer, A., Kusec, V., Machado, A., Misbah, S. A., Oosterhuis, W., Pulkki, K., Twomey, P. J., & Wieland, E.
- Venue
- Journal of Clinical Pathology
- Publisher
- BMJ
- Published
- 2017-12-22
- Volume
- 72
- Issue
- 3
- Pages
- 191-197
- ISSN
- 0021-9746 (ISSN-L)
- 1472-4146
- OpenAlex
- W2777453889
- Cited by
- 59
- References
- 2
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.